Japanese Circulation Society

Short and Long Term Effect of the Combination Therapy of Epoprostenol and Bosentan for Patients with Pulmonary Arterial Hypertension

Figure 1. The reduction in systemic pulmonary arterial pressure achieved with epoprostenol in the short-term was maintained at 1 year.